Cardiologia
Estudo randomizado de fase 2 | Baxdrostate para hipertensão resistente a tratamento
7 Fev, 2023 | 18:04hPhase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension – New England Journal of Medicine (link para o resumo – $ para texto completo)
Comentário no Twitter (fio – clique para saber mais)
Aldosterone has long been a pharmacologic target for the treatment of hypertension. However, a new small-molecule drug called baxdrostat inhibits aldosterone synthase in patients with treatment-resistant hypertension. 1/14 pic.twitter.com/F27WE4Wa1d
— NEJM (@NEJM) February 3, 2023
Estudo randomizado | Marca-passo em ritmo acelerado e personalizado pode melhorar a qualidade de vida em pacientes com insuficiência cardíaca com fração de ejeção preservada
7 Fev, 2023 | 17:52hEffect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction: The myPACE Randomized Clinical Trial – JAMA Cardiology (gratuito por tempo limitado)
Comunicado de imprensa: Speeding up heart rate helps heart failure patients with stiff hearts – University of Minnesota Medical School
Comentário no Twitter
In study of patients with HFpEF and pacemakers, moderately accelerated pacing (median pacing rate 75bpm) improved health-related QOL, natriuretic peptide levels, activity levels, and Afib compared w/ standard 60 bpm setting. https://t.co/Ow3W3qD6DM @maggieinfeld @markusmeyermd
— JAMA Cardiology (@JAMACardio) February 1, 2023
Os “10 mandamentos” das diretrizes ESC/ERS 2022 para o diagnóstico e o tratamento da hipertensão pulmonar
7 Fev, 2023 | 15:31hDiretriz original: #ESCCongress | 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Estudo de caso-controle | Associação entre antraciclinas e insuficiência cardíaca em pacientes tratados para câncer de mama ou linfoma, 1985-2010
7 Fev, 2023 | 15:26hComentário convidado: Heart Failure in Patients With Cancer Treated With Anthracyclines—Revisiting the Foundation of Cardio-Oncology- JAMA Network Open
Comentário no Twitter
Anthracycline is linked to double the rate of heart failure in patients with cancer vs matched controls, 7.4% at 15 years. https://t.co/SxlJkJ7oLR
— JAMA Network Open (@JAMANetworkOpen) February 3, 2023
M-A | Ressincronização cardíaca pode melhorar os desfechos em pacientes com atraso na condução intraventricular, mas não naqueles com bloqueio de ramo direito
7 Fev, 2023 | 15:20hCardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials – Circulation (gratuito por tempo limitado)
Comentário: CRT Likely Benefits Broader Group of Patients: Meta-analysis – TCTMD
Comentário no Twitter
#OriginalResearch: In this patient level meta-analysis of RCTs, #CRT was associated with better outcomes in patients with QRS ≥150ms and IVCD or LBBB, but not RBBB @DanFriedmanMD @DrMGold1 @AnneBCurtis @VKutyifa @FudimMarat @F_dalgaard https://t.co/ptW1u9Op1E pic.twitter.com/qBxbiMxz4S
— Circulation (@CircAHA) February 1, 2023
Estudo randomizado | Ressuscitação cardiopulmonar (RCP) extracorpórea precoce não melhorou os desfechos em pacientes com parada cardíaca refratária fora do ambiente hospitalar
31 Jan, 2023 | 12:43hEarly Extracorporeal CPR for Refractory Out-of-Hospital Cardiac Arrest – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário: Early Extracorporeal CPR for Out-of-Hospital Cardiac Arrest – American College of Cardiology
Comentário no Twitter
In a randomized trial, patients with out-of-hospital cardiac arrest who received extracorporeal CPR and those who received conventional CPR had similar results for survival and favorable neurologic outcomes. https://t.co/Irw8nrV8AA pic.twitter.com/lOPsBzhP3O
— NEJM (@NEJM) January 27, 2023
Risco e trajetória da doença cardiovascular isquêmica prematura em mulheres com histórico de pré-eclâmpsia: estudo nacional baseado em registro
31 Jan, 2023 | 12:34hRisk and trajectory of premature ischaemic cardiovascular disease in women with a history of pre-eclampsia: a nationwide register-based study – European Journal of Preventive Cardiology (gratuito por tempo limitado)
Comunicado de imprensa: Pre-eclampsia linked with four-fold higher risk of heart attack in decade after delivery – European Society of Cardiology
Comentários:
Preeclampsia Increases Heart Attack, Stroke Risk for Up to 20 Years After Pregnancy – HCP Live
Preeclampsia in Pregnancy a Bad Sign for Women’s Future Heart Health – HealthDay
Conteúdos relacionados:
AHA Scientific Statement | Adverse Pregnancy Outcomes and Cardiovascular Disease Risk
Cohort Study: Preeclampsia and Cardiovascular Disease
All Hypertensive Disorders of Pregnancy Increase the Risk of Future Cardiovascular Disease
Gestational Hypertension and Future Risk of Cardiovascular Disease
Diretriz | Recomendações para o uso da ecocardiografia na avaliação da doença cardíaca reumática
31 Jan, 2023 | 12:26hComentários:
ASE releases updated rheumatic heart disease guideline – Cardiovascular Business
Role of ECHO Emphasized in Management of Rheumatic Heart Disease – HealthDay
Comentário no Twitter
NEW GUIDELINE: Read our newest #guideline, "Recommendations for the Use of Echocardiography in the Evaluation of Rheumatic Heart Disease," in our January @JournalASEcho! https://t.co/Rf0BL3grm6 pic.twitter.com/tHCJDlzbqp
— American Society of Echocardiography (@ASE360) January 5, 2023
Diretriz AHA | Hipertensão relacionada ao tratamento oncológico
23 Jan, 2023 | 13:46hPrincipais tópicos a saber: Cancer Therapy-Related HTN – American Heart Association
Revisão | Síndrome de Wellens: uma importante consideração em pacientes com dor torácica
23 Jan, 2023 | 13:18hWellens syndrome: An important consideration in patients with chest pain – JAAPA
Comentário: Wellens Syndrome Important to Consider if Chest Pain: Key Points – American College of Cardiology